The Size of the Global African Horse Sickness Treatment Market is valued at USD xx billion in 2019 and estimated to be growing at a CAGR of xx%, to reach USD xx billion by 2024 during the forecast period 2019-2024.
MARKET OVERVIEW
African horse sickness is caused by a virus of the genus Orbivirus belonging to the family Reoviridae which is a highly infectious and deadly disease and it commonly affects horses, mules, and donkeys. This virus is commonly known as the African Horse Sickness Virus. It is not directly contagious, but is known to be spread by insect vectors and can be caused by any of the nine serotypes of this virus. This disease has a mortality rate of 95% in horses, which are most susceptible to the disease, while mules and donkeys are less likely to African horse sickness disease.
The good vaccination program is the best preventive method for African horse sickness treatment. In addition, good nutritional program and regular deworming which forms an integral part of horse health. The affected horses are slaughtered usually, where the uninfected horses are vaccinated against the virus. These types of prevention programs are efficient and cost-effective ways to prevent common infectious diseases in a horse.
DRIVERS
Presence of guidelines and standard operating procedures for African horse sickness disease, rising in research and development programs for various preventive vaccines, increasing awareness regarding vaccination of horses, rising healthcare infrastructure, increase in disposable income and technology innovations in the medical sector are driving the growth of the market. However, a multivalent vaccine that does not guarantee that the horses are completely protected from the African horse sickness and high vaccine cost is hampering the growth of the market.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By clinical Form, Diagnosis, Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
Veterinary Serum and Vaccine Research Institute and Onderstepoort Biological Products SOC Ltd. |
This market research report on Global African Horse Sickness Treatment Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2024.
African Horse Sickness Treatment Market - By Clinical Form:
African Horse Sickness Treatment Market - By Diagnosis:
Regional Analysis:
North America followed by Europe has the largest revenue in the Global African horse sickness treatment market due to the presence of USDA organization in the US which deals with the standard operating procedures for the African horse sickness disease. Asia-Pacific is the fastest growing market due to the emerging economies and rise in the awareness about the vaccination of the horses.
Promising Companies leading the Global African Horse Sickness Treatment Market Profiled are Veterinary Serum and Vaccine Research Institute and Onderstepoort Biological Products SOC Ltd.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Clinical forms
5.1.1 Introduction
5.1.2 Dikkop or Cardiac form
5.1.3 Dunkop or Pulmonary form
5.1.4 Horse sickness fever
5.1.5 Mixed form
5.1.6 Y-o-Y Growth Analysis, By Clinical forms
5.1.7 Market Attractiveness Analysis, By Clinical forms
5.1.8 Market Share Analysis, By Clinical forms
5.2 Diagnosis
5.2.1 Introduction
5.2.2 Prevention treatment
5.2.2.1 Vaccines
5.2.3 Diagnostic tests
5.2.3.1 Laboratory tests for viral antigens
5.2.3.2 Serological tests
5.2.4 Y-o-Y Growth Analysis, By Diagnosis
5.2.5 Market Attractiveness Analysis, By Diagnosis
5.2.6 Market Share Analysis, By Diagnosis
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Clinical forms
6.1.3.3 By Diagnosis
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Clinical forms
6.1.4.3 By Diagnosis
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Clinical forms
6.1.5.3 By Diagnosis
6.2 North America
6.2.1 Introduction
6.2.2 United States
6.2.3 Canada
6.3 Europe
6.3.1 Introduction
6.3.2 U.K
6.3.3 Spain
6.3.4 Germany
6.3.5 Italy
6.3.6 France
6.4 Asia-Pacific
6.4.1 Introduction
6.4.2 China
6.4.3 India
6.4.4 Japan
6.4.5 Australia
6.4.6 South Korea
6.5 Latin America
6.5.1 Introduction
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Rest of Latin America
6.6 Middle East & Africa
6.6.1 Introduction
6.6.2 Middle-East
6.6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Veterinary Serum and Vaccine Research Institute
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Onderstepoort Biological Products SOC
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
